VIVEX Biologics, Inc. Launches New Family of Allografts, VIAGENEX™

MIAMIMay 19, 2021 /PRNewswire/ — VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced the launch of VIAGENEX™, a family of amniotic allografts processed to retain the inherent mechanical properties of amniotic tissue and rich supply of extracellular matrix, growth factors, and cytokines read more